Perspective Therapeutics, Inc. (NYSE:CATX) Receives ... - ETF Daily …

Dec 28, 2024 · Shares of CATX opened at $3.19 on Wednesday. The stock’s fifty day simple moving average is $6.86 and its 200-day simple moving average is $10.79. Perspective …

$3.19
OFF

Perspective Therapeutics, Inc. (NYSE:CATX) Receives ... - ETF Daily …

2 weeks from now

Dec 28, 2024 · Shares of CATX opened at $3.19 on Wednesday. The stock’s fifty day simple moving average is $6.86 and its 200-day simple moving average is $10.79. Perspective …

etfdailynews.com

$4.36
OFF

Perspective Therapeutics, Inc. (NYSE:CATX) Receives ... - ETF Daily …

2 weeks from now

Nov 30, 2024 · NYSE CATX opened at $4.36 on Friday. The company has a fifty day moving average price of $10.60 and a 200-day moving average price of $12.27. Perspective …

etfdailynews.com

6%
OFF

Perspective Therapeutics, Inc. (NYSE:CATX) Shares ... - ETF Daily …

2 weeks from now

Dec 22, 2024 · State Street Corp grew its position in Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) by 119.6% in the third quarter, HoldingsChannel reports.The institutional …

etfdailynews.com

$3.76
OFF

MetLife Investment Management LLC Buys 19,137 Shares ... - ETF …

2 weeks from now

Dec 8, 2024 · Perspective Therapeutics Price Performance. NYSE CATX opened at $3.76 on Friday. The company has a fifty day simple moving average of $9.75 and a 200 day simple …

etfdailynews.com

$227
OFF

Perspective Therapeutics Advances Cancer Pipeline With $227.8M …

2 weeks from now

2 days ago · Perspective Therapeutics (NYSE AMERICAN: CATX) has provided strategic updates and priorities for the next 12-18 months. The company reported preliminary unaudited cash …

stocktitan.net

9%
OFF

Barclays PLC Boosts Stock Position In Perspective Therapeutics, Inc ...

2 weeks from now

3 days ago · Barclays PLC lifted its position in Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) by 587.9% in the third quarter, Holdings Channel.com reports. The firm owned …

etfdailynews.com

$3.19
OFF

Geode Capital Management LLC Acquires 129,654 Shares ... - ETF …

2 weeks from now

Dec 30, 2024 · View Our Latest Stock Analysis on Perspective Therapeutics. Perspective Therapeutics Trading Down 3.0 %. Shares of CATX opened at $3.19 on Monday. Perspective …

etfdailynews.com

FAQs about Perspective Therapeutics, Inc. (NYSE:CATX) Receives ... - ETF Daily … Coupon?

Is perspective Therapeutics a good stock to buy?

UBS Group initiated coverage on shares of Perspective Therapeutics in a research report on Thursday, October 24th. They issued a “buy” rating and a $20.00 target price on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Perspective Therapeutics in a research report on Monday, September 9th. ...

How much revenue did perspective Therapeutics make in a quarter?

The company had revenue of $0.37 million for the quarter. As a group, analysts forecast that Perspective Therapeutics, Inc. will post -0.88 earnings per share for the current fiscal year. In other news, CEO Johan M. Spoor purchased 14,500 shares of the business’s stock in a transaction on Monday, November 25th. ...

How much EPs will perspective Therapeutics (PTC) post in fiscal year?

On average, sell-side analysts predict that Perspective Therapeutics, Inc. will post -0.88 EPS for the current fiscal year. In other news, CEO Johan M. Spoor acquired 14,500 shares of the firm’s stock in a transaction on Monday, November 25th. ...

Who owns perspective Therapeutics?

Point72 DIFC Ltd purchased a new stake in Perspective Therapeutics during the 2nd quarter valued at $118,000. Finally, Intech Investment Management LLC bought a new stake in Perspective Therapeutics in the 3rd quarter worth $137,000. Hedge funds and other institutional investors own 54.66% of the company’s stock. ...

How much is MetLife Investment Management LLC's catx stock worth?

MetLife Investment Management LLC’s holdings in Perspective Therapeutics were worth $416,000 as of its most recent filing with the Securities and Exchange Commission (SEC). A number of other hedge funds and other institutional investors also recently made changes to their positions in CATX. ...

Which large investors have modified their holdings of perspective Therapeutics?

Several other large investors have also recently modified their holdings of the stock. nVerses Capital LLC bought a new stake in Perspective Therapeutics in the third quarter valued at approximately $57,000. US Bancorp DE raised its holdings in Perspective Therapeutics by 142.7% during the 3rd quarter. ...